---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-006844"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T06:03:39.447946+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor Q1 adj EPS $0.23, revenue $2.63B; reaffirms FY guide, active on P&HS sale

## Summary
- Adjusted EPS $0.23 vs $0.19 YoY; GAAP net loss $(0.32) per share vs $(0.29).
- Revenue $2.63B (+0.7% YoY); Patient Direct segment margin +173 bps.
- Adjusted EBITDA $121.9M vs $116.3M YoY; full-year 2025 guidance reaffirmed.
- Company actively engaged in potential sale of Products & Healthcare Services segment.
- Integrating planned Rotech acquisition; monitoring tariff policy impacts.

## SEC filing metadata
- accession: 0001558370-25-006844
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000155837025006844/0001558370-25-006844-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000155837025006844/omi-20250508x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-006844
- JSON: https://secwatch.observer/filing/0001558370-25-006844.json
- Plain text: https://secwatch.observer/filing/0001558370-25-006844.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.